These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1535768)

  • 1. Immunosuppression in vitro and in vivo by supernatants from murine lymphoma cell lines.
    Klajman A; Drucker I; Zan-Bar I; Mekori Y; Ben-Efraim S
    Anticancer Res; 1992; 12(3):741-7. PubMed ID: 1535768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of immunosuppressive factor(s) by MOPC-315 murine plasmacytoma cells: a possible mechanism of defence.
    Bomstein Y; Ophir R; Harshemes H; Ben-Efraim S
    Anticancer Res; 1993; 13(6A):2125-9. PubMed ID: 8297124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionation of lymphocyte subpopulations which regulate mixed lymphocyte reactions.
    Rich RR; Chu L; Rich SS
    J Immunol; 1977 Apr; 118(4):1252-8. PubMed ID: 139451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10.
    Rivas JM; Ullrich SE
    J Immunol; 1992 Dec; 149(12):3865-71. PubMed ID: 1460278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of unique lymphoid cells derived from murine spleen which constitutively produce interleukin-6.
    O'Neill HC; Ni K
    Immunology; 1993 Jun; 79(2):220-8. PubMed ID: 8344701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro generation of suppressor cell activity: suppression of in vitro induction if cell-mediated cytotoxicity.
    Hodes RJ; Hathcock KS
    J Immunol; 1976 Jan; 116(1):167-77. PubMed ID: 128570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective growth of murine newborn-derived suppressor cells and their probable mode of action.
    Jadus MR; Parkman R
    J Immunol; 1986 Feb; 136(3):783-92. PubMed ID: 2934478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
    Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR
    J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
    Teh HS; Yu M
    J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes.
    Yamamoto H; Hirayama M; Genyea C; Kaplan J
    J Immunol; 1994 Apr; 152(8):3842-7. PubMed ID: 8144953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characteristics of BALB/c T cell lines: suppression in the mixed lymphocyte response and cell-mediated lysis.
    Kim KJ; Weinbaum FI; Asofsky R
    J Immunol; 1978 Dec; 121(6):2299-304. PubMed ID: 152791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of immune response in allogeneic mixed spleen cell cultures. I. Influence of I-region on the generation of suppressor cells.
    Kim YT; Schwartz A; Moody C; Siskind GW; Weksler ME
    J Immunol; 1980 Oct; 125(4):1724-9. PubMed ID: 6447730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of B cells in the stimulation of syngeneic mixed lymphocyte responses.
    Thorbecke GJ; Chapman-Alexander J; Katz IR; Bienenstock A; Asofsky R
    Behring Inst Mitt; 1983 May; (72):107-16. PubMed ID: 6242330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of immunosuppressive factor(s) by a weakly immunogenic fibrosarcoma T 241.
    Gautam SC
    Anticancer Res; 1983; 3(4):263-8. PubMed ID: 6224458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of NKCF-like activity in mixed lymphocyte-tumor cell culture: direct involvement of mycoplasma infection of tumor cells.
    Wayner EA; Brooks CG
    J Immunol; 1984 Apr; 132(4):2135-42. PubMed ID: 6230401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
    Sakurai T; Yamada M; Simamura S; Motoyoshi K
    Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.